Connection

Nathan Dolloff to Histone Deacetylase Inhibitors

Back to Details
This is a "connection" page, showing publications Nathan Dolloff has written about Histone Deacetylase Inhibitors.
Nathan Dolloff
Connection Strength
0.993
Histone Deacetylase Inhibitors
  1. ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase Inhibitors. Cancer Res. 2020 08 15; 80(16):3279-3291.
    View in: PubMed
    Score: 0.633
  2. PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma. Cancer Chemother Pharmacol. 2022 05; 89(5):643-653.
    View in: PubMed
    Score: 0.179
  3. Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity. J Med Chem. 2020 05 28; 63(10):5501-5525.
    View in: PubMed
    Score: 0.157
  4. Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model. Mol Cancer Ther. 2013 Jun; 12(6):1140-50.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.